Overview
Paul Russo is an Urologist in New York, New York. Dr. Russo is highly rated in 25 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery.
His clinical research consists of co-authoring 319 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
1275 York Ave, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mskcc Surgery Group
Jonathan Coleman is an Urologist in New York, New York. Dr. Coleman is highly rated in 27 conditions, according to our data. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy.
Icahn School Of Medicine At Mount Sinai
John Sfakianos is an Urologist in Long Island City, New York. Dr. Sfakianos is highly rated in 25 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
Mskcc Surgery Group
Guido Dalbagni is an Urologist in New York, New York. Dr. Dalbagni is highly rated in 24 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy. Dr. Dalbagni is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Bladder Cancer
- Choriocarcinoma
- Clear Cell Sarcoma
- Empyema
- Familial Wilms Tumor 2
- Muscle Invasive Bladder Cancer
- Advanced
- Congenital Mesoblastic Nephroma
- Familial Prostate Cancer
- Malakoplakia
- Non-Muscle Invasive Bladder Cancer
- Penile Cancer
- Reconstructive Urology Surgery